Table 1.

Indications for liver resection in 2012 patients

Indication	n (%)
Malignant (n = 1453)
Primary tumours	701 (48.2%)
Hepatocellular carcinoma	450 (30.9%)
Biliary tumours	194 (13.4%)
Intrahepatic carcinoma	81 (5.6%)
Hilar carcinoma	78 (5.4%)
Gallbladder carcinoma	35 (2.4%)
Others	57 (3.9%)
Secondary tumours	752 (51.8%)
Colorectal metastases	546 (37.6%)
Neuroendocrine metastases	115 (7.9%)
Other metastases	91 (6.3%)
Benign (n = 559)
Adenoma	129 (23.1%)
Focal nodular hyperplasia	61 (10.9%)
Haemangioma	32 (5.7%)
Hydatid and cystic disease	77 (13.8%)
Polycystic liver disease	40 (7.2%)
Living donor transplant	93 (16.6%)
Hepatolithiasis	32 (5.7%)
Others	95 (16.9%)